HOWL
HOWL
NASDAQ · Biotechnology

Werewolf Therapeutics Inc

$0.61
+0.01 (+1.02%)
As of Feb 8, 2:22 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 5.14M 4.74M 5.21M
Net Income 951.6K 665.5K 945.6K
EPS
Profit Margin 18.5% 14.0% 18.1%
Rev Growth -9.9% +8.5% -0.4%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.67M 2.50M 2.38M
Total Equity 23.33M 23.90M 24.74M
D/E Ratio 0.11 0.10 0.10
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.31M 1.24M 1.40M
Free Cash Flow 380.5K 530.0K 488.3K